Please try another search
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company’s products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Jong-Seo Lee | 61 | - | Member of Scientific Advisory Board |
Johan Sven Erik Rockberg | 45 | - | Member of Scientific Advisory Board |
Shim Hyun-Bo | - | - | Member of Scientific Advisory Board |
Kim Kyu-Tae | - | - | Chief Scientific Officer and Member of Scientific Advisory Board |
Mathias Uhlen | 70 | - | Member of Scientific Advisory Board |
Henrik Wernerus | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review